BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2025 12:36:25 PM | Browse: 430 | Download: 1090
 |
Received |
|
2025-03-26 09:29 |
|
Peer-Review Started |
|
2025-03-26 09:29 |
|
First Decision by Editorial Office Director |
|
2025-04-11 09:36 |
|
Return for Revision |
|
2025-04-11 09:36 |
|
Revised |
|
2025-04-21 16:18 |
|
Publication Fee Transferred |
|
2025-04-23 08:48 |
|
Second Decision by Editor |
|
2025-06-30 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-06-30 08:15 |
|
Articles in Press |
|
2025-06-30 08:15 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-07 06:57 |
|
Publish the Manuscript Online |
|
2025-08-25 12:36 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian-Yu Liu, Zhi-Hui Liang, Jing-Lei Liu, Liang Li, Bao Cui and Tie-Gang Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| 2023 Hebei Provincial Medical Scientific Research Project Plan |
20231304 |
|
| Corresponding Author |
Jian-Yu Liu, Associate Chief Physician, MD, Department of Interventional Treatment, Bethune International Peace Hospital of PLA, No. 398 Zhongshan West Road, Qiaoxi District, Shijiazhuang 050082, Hebei Province, China. ljiany109527@163.com |
| Key Words |
Colorectal cancer; Liver metastasis; Transarterial chemoembolization; Targeted therapy; Bevacizumab; Treatment outcomes |
| Core Tip |
This study investigates the combination of transarterial chemoembolization and targeted therapies (bevacizumab, cetuximab, and panitumumab) for the treatment of postoperative recurrent colorectal cancer with liver metastasis. The results indicate that this multimodal approach improved overall survival (28 months) and progression-free survival (12 months), with bevacizumab showing superior outcomes. The treatment is well tolerated, with manageable adverse events, and significantly enhances the patients’ quality of life. This combination therapy has the potential to be an effective and safe strategy for this challenging clinical scenario. |
| Publish Date |
2025-08-25 12:36 |
| Citation |
Liu JY, Liang ZH, Liu JL, Li L, Cui B, Li TG. Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis. World J Gastrointest Surg 2025; 17(8): 104568
|
| URL |
https://www.wjgnet.com/1948-9366/full/v17/i8/104568.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v17.i8.104568 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
